Penn's active research and clinical trials provide additional resources for kidney transplant patients. See below for kidney transplantation clinical trials conducted at Penn.
- A Phase 2 Double-Blind, Double-dummy, Multicenter, Prospective, Randomized Study of the Pharmacokinetics of LCP-Tacro Tablets, Once-Daily, Compared to Prograf Capsules, Twice-daily, for the Prevention of Acute Allograft Rejection in De Novo Adult Kidney Transplant Recipients
-
- Investigator: Roy D. Bloom, MD
- Clinical trials in organ transplantation (CTOT)
-
- Investigator: Abraham Shaked, MD, PhD
- Sponsored by: National Institutes of Health
- End Stage Disease and Mortality after Kidney Donation: A Determination of Incidence
-
- Investigator: Peter Abt, MD
- Determination of Sensitization after Transplant Nephrectomy
-
- Investigator: Peter Abt, MD
- The Impact of Donor Hemodynamic Events on Kidney and Liver Allograft Outcomes in Donation after Cardiac Death Donors
-
- Investigator: Peter Abt, MD
- Effect of Thymoglobulin versus Basiliximab on Regulatory T Cell Function in Live Donor Kidney Transplant Recipients
-
- Investigator: Matthew Levine, MD, PhD
- Solid Organ Transplant After Hematopoietic Cell Transplantation (HCT)
-
- Investigator: Matthew Levine, MD, PhD
For more information about clinical trials at the Penn Transplant Institute, see Research & Clinical Trials.